Navigation Links
Arthritis Foundation Launches "Prescription for Access" Toolkit to Support People With Arthritis by Delivering Resources to Help With Health Coverage and Denied Claims
Date:1/31/2017

ATLANTA, Jan. 31, 2017 /PRNewswire-USNewswire/ -- The pain and management of arthritis may not be visible, but it is incredibly real to the 50 million Americans diagnosed with arthritis and related diseases. Adding to this population's challenges are mounting concerns about the future of America's health care system and how to navigate its complexities. In response to the arthritis community, the Arthritis Foundation launched Prescription for Access, an initiative to address the arthritis community's concerns and provide people with arthritis the necessary tools to help them live a life of Yes.

As part of the Prescription for Access initiative, the Foundation recently held multiple meetings with health care executives, policymakers and patients to better understand the challenges patients with arthritis face in today's health care system. From these meetings, the Foundation believes the most logical way to "re-connect" America's health care system is to involve patients and make sure their voices are represented in the new legislation.

"We're fighting for millions of Americans with arthritis to make health care more accessible and to reduce the complexity of accessing and staying on their medications," said Sandie Preiss, vice president of advocacy and access, Arthritis Foundation. "A critical part of the Prescription for Access initiative is equipping patients with the tools and resources they need to understand their health care and how to get to 'Yes' when managing a claim denial through the appeal process."

The Prescription for Access Toolkit puts the necessary tools and resources right at patients' fingertips. This powerful resource helps patients better understand their health care coverage options, determine how their current plan meets their arthritis care needs as well as guide them through the clam denial process, including step-by-step instructions, sample letters and consumer assistance information.

To learn more about the Prescription for Access initiative, including recent work with government leaders and organizations, please visit www.arthritis.org/prescription-for-access

About the Arthritis Foundation:
The Arthritis Foundation is the Champion of Yes. Leading the fight for the arthritis community, the Foundation helps conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. The Arthritis Foundation's goal is to chart a winning course, guiding families in developing personalized plans for living a full life – and making each day another stride toward a cure. The Foundation also publishes Arthritis Today, the award-winning magazine that reaches 4 million readers.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arthritis-foundation-launches-prescription-for-access-toolkit-to-support-people-with-arthritis-by-delivering-resources-to-help-with-health-coverage-and-denied-claims-300398872.html


'/>"/>
SOURCE Arthritis Foundation
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment
2. Arthritis Foundation to Host Osteoarthritis Patient-Focused Drug Development Meeting
3. Global Rheumatoid Arthritis Partnering 2010 to 2016
4. Sun Pharma & Moebius Medical Sign Exclusive Global Licensing Deal to Develop Novel Liposomal Non-opioid Pain Product for Osteoarthritis
5. Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026
6. Prescription Chondroitin Sulphate is as Efficacious as Celecoxib and Better Than Placebo in Knee Osteoarthritis
7. Verschreibungspflichtiges Chondroitinsulfat ist bei Knie-Osteoarthritis genauso wirksam wie Celecoxib und besser als Placebos
8. Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
9. Osteoarthritis Pain Market (Drugs) to Grow at 8.38% CAGR Driven by Emergence of New Treatments to 2020
10. Osteoarthritis Pipeline Market H1 2016 Global Review Report
11. Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... April 19, 2017 Cardiology devices segment is anticipated ... The Cardiology Devices segment is likely to create ... Mn in 2018 over 2017. By the end of 2027, ... close to US$ 700 Mn, expanding at a CAGR of ... the Asia Pacific reprocessed medical devices ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and which He does not. Yisrayl says with so many titles and names for ... but he says with a little Scripture, backed with a lot of research, the truth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is ... Côté has 20+ years of experience within the beauty industry, ranging from marketing, ... array of high-end cosmetic brands, retail brands and outlets in Canada and New ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
Breaking Medicine News(10 mins):